$5.17
3.82% yesterday
Nasdaq, Sep 09, 10:07 pm CET
ISIN
US20451W1018
Symbol
CMPS

Compass Pathways Plc - ADR Stock price

$5.17
+0.83 19.12% 1M
+1.63 46.05% 6M
+1.39 36.77% YTD
-1.58 23.41% 1Y
-10.57 67.15% 3Y
-11.83 69.59% 5Y
-11.83 69.59% 10Y
-11.83 69.59% 20Y
Nasdaq, Closing price Tue, Sep 09 2025
+0.19 3.82%
ISIN
US20451W1018
Symbol
CMPS
Industry

Key metrics

Basic
Market capitalization
$481.0m
Enterprise Value
$290.1m
Net debt
positive
Cash
$221.9m
Shares outstanding
93.6m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
3.0
Financial Health
Equity Ratio
72.4%
Return on Equity
-100.3%
ROCE
-72.1%
ROIC
-
Debt/Equity
0.2
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-188.7m | $-178.8m
EBIT
$-189.0m | $-182.7m
Net Income
$-138.6m | $-143.1m
Free Cash Flow
$-148.5m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-22.6% | -0.5%
EBIT
-22.7% | -2.5%
Net Income
0.4% | 7.7%
Free Cash Flow
-48.8%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-1.5
FCF per Share
$-1.6
Short interest
9.1%
Employees
166
Rev per Employee
$0.0
Show more

Is Compass Pathways Plc - ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,018 stocks worldwide.

Compass Pathways Plc - ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Compass Pathways Plc - ADR forecast:

14x Buy
88%
2x Hold
13%

Analyst Opinions

16 Analysts have issued a Compass Pathways Plc - ADR forecast:

Buy
88%
Hold
13%

Financial data from Compass Pathways Plc - ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 63 63
27% 27%
-
- Research and Development Expense 126 126
23% 23%
-
-189 -189
23% 23%
-
- Depreciation and Amortization 0.31 0.31
55% 55%
-
EBIT (Operating Income) EBIT -189 -189
23% 23%
-
Net Profit -139 -139
0% 0%
-

In millions USD.

Don't miss a Thing! We will send you all news about Compass Pathways Plc - ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Compass Pathways Plc - ADR Stock News

Neutral
Seeking Alpha
about 7 hours ago
COMPASS Pathways plc (NASDAQ:CMPS ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 10:45 AM EDT Company Participants Kabir Nath - CEO & Director Guy Goodwin - Chief Medical Officer Lori Englebert - Chief Commercial Officer Teri Loxam - CFO, Principal Financial Officer & Principal Accounting Officer Conference Call Participants Judah Frommer - Morgan Stanley, Research ...
Neutral
Seeking Alpha
6 days ago
COMPASS Pathways plc (NASDAQ:CMPS ) Cantor Global Healthcare Conference 2025 September 3, 2025 1:35 PM EDT Company Participants Kabir Nath - CEO & Director Guy Goodwin - Chief Medical Officer Steve Levine - Chief Patient Officer Conference Call Participants Joshua Schimmer - Cantor Fitzgerald & Co., Research Division Presentation Joshua Schimmer Biotech Equity Research Analyst All right. Welcom...
Neutral
Business Wire
8 days ago
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the publication of results from an open-label Phase 2 study evaluating the safety and tolerability of a single-dose of 25 mg of investigational COMP360 synthetic psilocybin trea...
More Compass Pathways Plc - ADR News

Company Profile

Head office United Kingdom
CEO Kabir Nath
Employees 166
Founded 2016
Website compasspathways.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today